Biochemical predictors of outcome of pituitary surgery for cushing's disease

Neuroendocrinology

Volumn 91, Issue 2, 2010, Pages 169-178

  Alwani, R A ^a   De Herder, W W ^a   Van Aken, M O ^a   Van Den Berge, J H ^a   Delwel, E J ^a   Dallenga, A H G ^a   De Jong, F H ^a   Lamberts, S W J ^a   Van Der Lely, A J ^a   Feelders, R A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Corticotropin releasing hormone; Cortisol; Cushing's disease; Metyrapone; Pituitary adenoma; Pituitary surgery

Indexed keywords

AMOXICILLIN; CORTICOTROPIN RELEASING FACTOR; CORTODOXONE; DEXAMETHASONE; HYDROCORTISONE; KETOCONAZOLE; METYRAPONE;

ADRENALECTOMY; ADULT; ARTICLE; CHEMICAL ANALYSIS; CLINICAL EVALUATION; CONTROLLED STUDY; CUSHING DISEASE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPITUITARISM; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; REMISSION; RETROSPECTIVE STUDY; RISK FACTOR; STEREOTACTIC BODY RADIATION THERAPY; SURGICAL TECHNIQUE; TRANSSPHENOIDAL SURGERY; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; CORTICOTROPIN-RELEASING HORMONE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; KAPLAN-MEIERS ESTIMATE; MALE; METYRAPONE; PITUITARY ACTH HYPERSECRETION; PITUITARY FUNCTION TESTS; PITUITARY GLAND; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 77949913344     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000258677     Document Type: Article

References (39)

1. Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell- Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M: Treatment of ACTH-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2008; 93: 2454-2462.
2. Joshi SM, Cudlip S: Transsphenoidal surgery. Pituitary 2008; 11: 353-360.
3. Kelly DF: Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's syndrome. Neurosurg Focus 2007; 23:E5.
4. Patil CG, Prevedello DM, Lad SP, Vance ML, Thorner MO, Katznelson L, Laws ER Jr: Late recurrences of Cushing's disease after initial successful transsphenoidal surgery. J Clin Endocrinol Metab 2008; 93: 358-362.
5. Joshi SM, Hewitt RJ, Storr HL, Rezajooi K, Ellamushi H, Grossman AB, Savage MO, Afshar F: Cushing's disease in children and adolescents: 20 years of experience in a single neurosurgical center. Neurosurgery 2005; 57: 281-285.
6. Bochicchio D, Losa M, Buchfelder M: Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab 1995; 80: 3114-3120.
7. Invitti C, Pecori Giraldi F, De Martin M, Cavagnini F: Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 1999; 84: 440-448.
8. Tindall GT, Herring CJ, Clark RV, Adams DA, Watts NB: Cushing's disease: results of transsphenoidal microsurgery with emphasis on surgical failures. J Neurosurg 1990; 72: 363-369.
9. Chee GH, Mathias DB, James RA, Kendall- Taylor P: Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? Clin Endocrinol (Oxf) 2001; 54: 617-626.
10. Atkinson AB, Kennedy A, Wiggam MI, Mc- Cance DR, Sheridan B: Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Clin Endocrinol (Oxf) 2005; 63: 549-559.
11. Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF: Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single-centre using strict criteria for remission. Clin Endocrinol (Oxf) 2002; 56: 541-551.
12. Pereira AM, Van Aken MO, Van Dulken H, Schutte PJ, Biermasz NR, Smit JW, Roelfsema F, Romijn JA: Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease. J Clin Endocrinol Metab 2003; 88: 5858-5864.
13. Esposito F, Dusick JR, Cohan P, Moftakhar P, McArthur D, Wang C, Swerdloff RS, Kelly DF: Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 2006; 91: 7-13.
14. Estrada J, Garcia-Uria J, Lamas C, Alfaro J, Lucas T, Diez S, Salto L, Barcelo B: The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 2001; 86: 5695-5699.
15. Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB, Savage MO, Afshar F, Besser GM: Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf) 1993; 38: 73-78.
16. Yap LB, Turner HE, Adams CB, Wass JA: Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single-centre audit. Clin Endocrinol (Oxf) 2002; 56: 25-31.
17. Van Aken MO, De Herder WW, Van Der Lely AJ, De Jong FH, Lamberts SW: Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease. Clin Endocrinol (Oxf) 1997; 47: 145-149.
18. Avgerinos PC, Chrousos GP, Nieman LK, Oldfield EH, Loriaux DL, Cutler GB Jr: The corticotropin-releasing hormone test in the postoperative evaluation of patients with Cushing's syndrome. J Clin Endocrinol Metab 1987; 65: 906-913.
19. Pieters GF, Hermus AR, Meijer E, Smals AG, Kloppenborg PW: Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease. J Clin Endocrinol Metab 1989; 69: 1122-1126.
20. Schrell U, Fahlbusch R, Buchfelder M, Riedl S, Stalla GK, Muller OA: Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease. J Clin Endocrinol Metab 1987; 64: 1150-1159.
21. Vignati F, Berselli ME, Loi P: Early postoperative evaluation in patients with Cushing's disease: usefulness of ovine corticotropinreleasing hormone test in the prediction of recurrence of disease. Eur J Endocrinol 1994; 130: 235-241.
22. Hardy J: Transsphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg 1969; 16: 185-217.
23. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler GB Jr, Loriaux DL: Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 1991; 325: 897-905.
24. Antimicrobial prophylaxis in neurosurgery and after head injury. Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy. Lancet 1994; 344: 1547-1551.
25. Van Aken MO, De Marie S, Van Der Lely AJ, Singh R, Van Den Berge JH, Poublon RM, Fokkens WJ, Lamberts SW, De Herder WW: Risk factors for meningitis after transsphenoidal surgery. Clin Infect Dis 1997; 25: 852-856.
26. Spark RF: Simplified assessment of pituitary- adrenal reserve. Measurement of serum 11-deoxycortisol and cortisol after metyrapone. Ann Intern Med 1971; 75: 717-723.
27. Prevedello DM, Pouratian N, Sherman J, Jane JA Jr, Vance ML, Lopes MB, Laws ER Jr: Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging. J Neurosurg 2008; 109: 751-759.
28. Woo YS, Isidori AM, Wat WZ, Kaltsas GA, Afshar F, Sabin I, Jenkins PJ, Monson JP, Besser GM, Grossman AB: Clinical and biochemical characteristics of adrenocorticotropin- secreting macroadenomas. J Clin Endocrinol Metab 2005; 90: 4963-4969.
29. Swearingen B, Biller BM, Barker FG 2nd, Katznelson L, Grinspoon S, Klibanski A, Zervas NT: Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med 1999; 130: 821-824.
30. Van Aken MO, Pereira AM, Biermasz NR, Van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SW, Romijn JA: Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab 2005; 90: 3279-3286.
31. Feldt-Rasmussen U, Abs R, Bengtsson BA, Bennmarker H, Bramnert M, Hernberg- Stahl E, Monson JP, Westberg B, Wilton P, Wuster C: Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease. Eur J Endocrinol 2002; 146: 67-74.
32. Netea-Maier RT, Van Lindert EJ, Den Heijer M, Van Der Eerden A, Pieters GF, Sweep CG, Grotenhuis JA, Hermus AR: Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing's disease. Eur J Endocrinol 2006; 154: 675-684.
33. Mullan KR, Atkinson AB: Endocrine clinical update: where are we in the therapeutic management of pituitary-dependent hypercortisolism? Clin Endocrinol (Oxf) 2008; 68: 327-337.
34. Newell-Price J, Morris DG, Drake WM, Korbonits M, Monson JP, Besser GM, Grossman AB: Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab 2002; 87: 1640-1645.
35. Reimondo G, Paccotti P, Minetto M, Termine A, Stura G, Bergui M, Angeli A, Terzolo M: The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome. Clin Endocrinol (Oxf) 2003; 58: 718-724.
36. Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DL, Cutler GB Jr: A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 1993; 77: 1308-1312.
37. Courtney CH, McAllister AS, McCance DR, Hadden DR, Leslie H, Sheridan B, Atkinson AB: The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic-pituitary-adrenal axis following pituitary surgery. Clin Endocrinol (Oxf) 2000; 53: 309-312.
38. Fiad TM, Kirby JM, Cunningham SK, Mc- Kenna TJ: The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary- adrenal axis. Clin Endocrinol (Oxf) 1994; 40: 603-609.
39. Giordano R, Picu A, Bonelli L, Balbo M, Berardelli R, Marinazzo E, Corneli G, Ghigo E, Arvat E: Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo- pituitary disorders: comparison of different provocative tests. Clin Endocrinol (Oxf) 2008; 68: 935-941.